Background: It has been suggested that the use of sunscreens to prevent skin cancer may put the population at risk of vitamin D deficiency, which in turn may lead to secondary hyperparathyroidism, loss of cortical bone and, ultimately, osteoporotic fractures. Objective: To investigate whether sunscreen SPF15 may lead to loss of bone mass. Methods: We followed 10 sunscreen users and 18 controls over 2 years, including two summers, two winters and a basal period (winter). Bone mass was evaluated each season with dual x-ray absorptiometry. Results: During follow-up, mild fluctuations in bone mass could be seen at Ward’s site in both groups, without a definitive pattern. At the final visit, no significant loss of bone mass was observed in sunscreen users or in the control group. We did not observe any significant differences between groups throughout the study. Conclusion: Although the study samples in this work are small, and a slight variation in bone mass may not be detected, in a clinical setting, sunscreen SPF15 protection does not seem to increase the risk of osteoporosis.

Keywords:
Sunscreen, Skin cancer prevention, Elderly, Osteoporosis
1.
Holick MF: McCollum Award Lecture, 1994: Vitamin D – new horizons for the 21st century. Am J Clin Nutr 1994;60:619–630.
2.
Demay MB, Roth DA, Kronenberg HM: Regions of the rat osteocalcin gene which mediate the effect of 1,25-dihydroxyvitamin D3 gene transcription. J Biol Chem 1989;264:2279–2282.
3.
Chang PL, Ridal AL, Prince CW: Calcitriol regulation of osteopontin expression in mouse epidermal cells. Endocrinology 1994;135:863–869.
4.
Pathak MA, Fitzpatrick TB: Preventive treatment of sunburn, dermatoheliosis, and skin cancer with sun-protective agents; in Fitzpatrick TB, Eisen AZ, Wolff K, et al (eds): Dermatology in General Medicine, ed 4. New York, McGraw Hill, 1993, vol 1, pp 1689–1717.
5.
Matsuoka LY, Ide L, Wortsman J, McLauughlin JA, Holick MF: Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987;64:1165–1168.
6.
Matsuoka LY, Wortsman J, Hanifan N, Holick MF: Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D: A preliminary study. Arch Dermatol 1988;124:1802–1804.
7.
Chapuy MC, Arlot M, Duboeuf F, et al: Vitamin D and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637–1642.
8.
Farrerons J, Barnadas M, Rodríguez J, Renau A, Yoldi B, López-Navidad A, Moragas J: Clinically prescribed sunscreen (sun protection factor 15) does not decrease serum vitamin D concentration sufficiently either to induce changes in parathyroid function or in metabolic markers. Br J Dermatol 1998;139:422–427.
9.
Holick MF: The photobiology of vitamin D and its consequences for humans. Ann NY Acad Sci 1985;453:1–13.
10.
Cole CA, Forbes PD, Davies RE: An action spectrum for UV photocarcinogenesis. Photochem Photobiol 1986;43:275–284.
11.
Reichel HK, Koeffler HP, Norman AW: The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989;15:980–990.
12.
Marks R, Foley PA, Jolley D, Knight KR, Harrison J, Thompson SC: The effect of regular sunscreen use on vitamin D levels in an Australian population. Arch Dermatol 1995;131:415–421.
13.
Sollito RB, Kraemer KH, DiGiovanna JJ: Normal vitamin D levels can be maintained despite rigorous photoprotection: Six years’ experience with xeroderma pigmentosum. J Am Acad Dermatol 1997;37:942–947.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.